Paul Tudor Jones’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Paul Tudor Jones’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2,099	Closed	-$203K	–	1648
2020 Q2	$203K	Buy	+2,099	New	+$175K	0.01%	1025
2019 Q2	–	Sell	-5,000	Closed	-$260K	–	1442
2019 Q1	$260K	Buy	+5,000	New	+$230K	0.01%	915
2016 Q4	–	Sell	-20,000	Closed	-$327K	–	1701
2016 Q3	$327K	Buy	+20,000	New	+$361K	0.01%	972

Other funds holding MYOK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Paul Tudor Jones's MYOK Position: Q3 2020 in Review

Paul Tudor Jones sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2020, closing a stake of 2,099 shares — an estimated $203K sold.

Paul Tudor Jones first reported a position in MYOK in Q3 2016 and held it in 3 quarters. The position peaked at $327K in Q3 2016. 237 funds tracked by Wall St. Rank hold MYOK as of Q3 2020.

Paul Tudor Jones reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
Paul Tudor Jones sold 2,099 MyoKardia, Inc. Common Stock shares in Q3 2020, an estimated $203K.
Paul Tudor Jones first reported a position in MyoKardia, Inc. Common Stock in Q3 2016 and held it in 3 quarters.
Paul Tudor Jones's MyoKardia, Inc. Common Stock position peaked at $327K in Q3 2016.
237 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2020.

Based on Tudor Investment Corp's 13F filing for Q3 2020, filed 16 Nov 2020.